SPRY ARS Pharmaceuticals, Inc.

Fundamentals / CIK 0001671858 / USD

ARS Pharmaceuticals, Inc. reported $122.1M in revenue and a net loss of $199.9M for the trailing twelve months ended September 30, 2026 (up 16.0% year over year), with a -161.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SPRY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$106.0M$52.98M$0-$167.7MFY 2020 Net Income: -$32.95M2020FY 2021 Revenue: $5.51MFY 2021 Net Income: -$20.24M2021FY 2022 Revenue: $1.32MFY 2022 Net Income: -$34.68M2022FY 2023 Revenue: $30KFY 2023 Net Income: -$54.37M2023FY 2024 Revenue: $89.15MFY 2024 Net Income: $8.00M2024FY 2025 Revenue: $84.28MFY 2025 Net Income: -$171.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $84.28M $89.15M $30K $1.32M $5.51M --
Cost of Revenue -- -- $0 -- -- --
Gross Profit -- -- $30K -- -- --
Research & Development $13.18M $19.58M $20.27M $18.38M $20.27M $24.58M
Selling, General & Admin $230.1M $71.67M $47.28M $603K -- --
Total Operating Expenses $263.7M $92.23M $67.55M $36.83M $24.96M $32.92M
Operating Income -$179.4M -$3.08M -$67.52M -$35.52M -$19.45M -$32.92M
EBITDA -$178.1M -$3.00M -$67.42M -$35.20M -$19.24M -$32.28M
Income Before Tax -$171.4M $8.29M -$54.37M -- -- --
Income Tax Expense -$80K $288K $0 $0 $0 $0
Net Income -$171.3M $8.00M -$54.37M -$34.68M -$20.24M -$32.95M
Basic EPS -$1.74 $0.08 -$0.57 -$0.87 -$0.70 -$11.33
Diluted EPS -$1.74 $0.08 -$0.57 -$0.87 -$0.70 -$11.33
Basic Shares Outstanding 98.6M 96.9M 95.2M 40.0M 28.9M 2.9M
Diluted Shares Outstanding 98.6M 102.4M 95.2M 40.0M 28.9M 2.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $37.71M $33.66M $22.68M $28.09M $32.50M $15.72M $7.97M $86.58M
Research & Development $18.26M $4.70M $4.34M $3.44M $2.75M $4.04M $2.95M $3.03M
Selling, General & Admin $43.52M $77.58M $72.20M $59.95M $74.75M $54.31M $41.10M $35.49M
Total Operating Expenses $71.88M $95.12M $82.83M $69.55M $85.69M $63.33M $45.15M $39.38M
Operating Income -$34.17M -$61.47M -$60.15M -$41.47M -$53.19M -$47.61M -$37.18M $47.20M
EBITDA -$33.76M -$61.05M -$59.75M -$41.05M -$52.80M -$47.34M -$36.90M $47.23M
Net Income -$35.59M -$62.34M -$60.62M -$41.32M -$51.15M -$44.88M -$33.94M $49.93M
Basic EPS -$0.36 -$0.63 -$0.61 -- -$0.52 -$0.46 -$0.35 --
Diluted EPS -$0.36 -$0.63 -$0.61 -- -$0.52 -$0.46 -$0.35 --
Basic Shares Outstanding 99.7M 99.3M 99.3M -- 98.8M 98.4M 98.1M --
Diluted Shares Outstanding 99.7M 99.3M 99.3M -- 98.8M 98.4M 98.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $41.32M $50.82M $70.97M $210.5M $60.06M $386.6M
Short-Term Investments $203.7M $263.2M $157.4M $63.86M $0 --
Cash & Short-Term Investments $245.0M $314.0M $228.4M $274.4M $60.06M $386.6M
Accounts Receivable, Net $25.35M $8.18M $0 -- -- --
Inventory $31.42M $10.52M $0 -- -- --
Total Current Assets $284.9M $334.3M $231.7M $277.7M $60.73M $390.7M
Property, Plant & Equipment, Net $2.46M $1.07M $574K $329K $72K $1.62M
Intangible Assets $14.45M $7.37M $0 -- -- --
Long-Term Investments -- -- -- -- $64.78M $0
Other Non-Current Assets -- -- -- $0 -- --
Total Non-Current Assets $42.76M $16.86M $1.46M $3.73M $716K $4.15M
Total Assets $327.7M $351.2M $233.2M $281.4M $61.45M $394.8M
Accounts Payable $5.72M $9.87M $759K $1.66M $1.79M $2.58M
Deferred Revenue (Current) $609K $557K $0 $283K $1.46M --
Other Current Liabilities $588K $42K -- -- -- --
Total Current Liabilities $39.15M $23.44M $2.39M $5.44M $8.19M $9.60M
Long-Term Debt $96.37M $0 -- -- -- --
Deferred Revenue (Non-Current) $1.13M $1.53M $0 $2.85M $3.00M --
Total Non-Current Liabilities $174.2M $70.92M $37K $3.10M $8.49M $2.33M
Total Liabilities $213.4M $94.36M $2.43M $8.55M $16.68M $11.93M
Total Debt (incl. Leases) $96.37M $42K $274K $481K $5.85M $3.22M
Common Stock $10K $10K $10K $9.0K $3.0K $3.0K
Retained Earnings -$294.6M -$123.3M -$131.3M -$76.94M -$42.26M -$96.73M
Accumulated Other Comp. Income $125K $220K $49K $407K $0 $0
Total Stockholders' Equity $114.3M $256.8M $230.8M $272.9M -$31.27M -$14.05M
Total Equity $114.3M $256.8M $230.8M $272.9M -$31.27M -$14.05M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $25.62M $8.16M $24.32M $41.32M $59.56M $51.54M $39.86M $50.82M
Short-Term Investments $112.7M $135.7M $176.6M $203.7M $228.7M $188.6M $235.9M $263.2M
Cash & Short-Term Investments $138.4M $143.8M $201.0M $245.0M $288.2M $240.1M $275.7M $314.0M
Accounts Receivable, Net $52.76M $46.84M $28.66M $25.35M $36.45M $25.13M $9.30M $8.18M
Inventory $33.43M $30.73M $32.04M $31.42M $21.43M $22.11M $7.27M $10.52M
Total Current Assets $211.0M $211.5M $245.2M $284.9M $338.9M $281.4M $303.9M $334.3M
Property, Plant & Equipment, Net $1.93M $2.08M $2.29M $2.46M $1.21M $1.07M $1.07M $1.07M
Intangible Assets $13.62M $13.90M $14.18M $14.45M $14.73M $12.97M $7.24M $7.37M
Total Non-Current Assets $40.46M $37.98M $42.34M $42.76M $33.94M $32.04M $23.46M $16.86M
Total Assets $251.5M $249.5M $287.6M $327.7M $372.8M $313.5M $327.3M $351.2M
Accounts Payable $5.42M $5.20M $4.71M $5.72M $8.38M $15.56M $4.09M $9.87M
Deferred Revenue (Current) $511K $535K $757K $609K $526K $746K $540K $557K
Other Current Liabilities $599K $596K $592K $588K -- -- -- $42K
Total Current Liabilities $64.90M $60.86M $49.61M $39.15M $50.88M $45.60M $27.62M $23.44M
Long-Term Debt $121.8M $96.68M $96.52M $96.37M $96.23M -- -- $0
Deferred Revenue (Non-Current) $1.05M $1.11M $978K $1.13M $1.27M $1.10M $1.34M $1.53M
Total Non-Current Liabilities $198.5M $176.1M $176.7M $174.2M $174.3M $75.55M $70.72M $70.92M
Total Liabilities $263.4M $237.0M $226.3M $213.4M $225.1M $121.2M $98.34M $94.36M
Total Debt (incl. Leases) $121.8M $96.68M $96.52M $96.37M $97.76M $1.66M $73K $42K
Common Stock $10K $10K $10K $10K $10K $10K $10K $10K
Retained Earnings -$453.1M -$417.6M -$355.2M -$294.6M -$253.3M -$202.1M -$157.2M -$123.3M
Accumulated Other Comp. Income -$104K -$140K -$96K $125K -$7.0K -$46K $72K $220K
Total Stockholders' Equity -$11.96M $12.51M $61.31M $114.3M $147.7M $192.3M $229.0M $256.8M
Total Equity -$11.96M $12.51M $61.31M $114.3M $147.7M $192.3M $229.0M $256.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$171.3M $8.00M -$54.37M -$34.68M -$20.24M -$32.95M
Depreciation & Amortization $1.37M $79K $100K $319K $213K $637K
Stock-Based Compensation $22.09M $14.53M $9.23M $5.84M $2.83M $2.64M
Change in Receivables -$17.20M -$8.18M $0 -- -- --
Change in Inventory -$21.99M -$5.95M $0 -- -- --
Operating Cash Flow -$170.9M $13.55M -$59.27M -$40.08M -$17.56M -$31.20M
Capital Expenditure -$339K -$563K -$175K -$199K -$55K -$917K
Free Cash Flow -$171.2M $12.98M -$59.44M -$40.28M -$17.62M -$32.11M
Purchases of Investments -- -- -- -- -$65.11M $0
Investing Cash Flow $56.77M -$106.1M -$87.18M -$199K -$55K -$917K
Financing Cash Flow $104.6M $72.40M $6.90M $190.7M $53.16M $408.5M
Net Change in Cash -$9.50M -$20.15M -$139.5M $150.5M $35.54M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$35.59M -$62.34M -$60.62M -$41.32M -$51.15M -$44.88M -$33.94M $49.93M
Depreciation & Amortization $415K $416K $397K $417K $391K $279K $280K $29K
Stock-Based Compensation $8.12M $12.39M $7.42M $5.74M $5.69M $5.37M $5.30M $4.26M
Change in Receivables -$5.89M -$20.63M -$839K $11.18M -$14.01M -$13.25M -$1.13M -$7.40M
Change in Inventory -$2.28M $13K -$294K -$9.72M $963K -$4.78M -$8.45M -$5.76M
Operating Cash Flow -$33.71M -$60.93M -$44.95M -$43.48M -$47.05M -$39.59M -$40.74M $42.00M
Capital Expenditure $0 $0 $0 $0 -$197K -$51K -$91K -$302K
Free Cash Flow -$33.71M -$60.93M -$44.95M -$43.48M -$47.24M -$39.64M -$40.83M $41.70M
Investing Cash Flow $23.41M $41.57M $27.79M $24.11M -$44.98M $48.57M $29.06M -$101.8M
Financing Cash Flow $27.76M $3.20M $159K $1.13M $100.0M $2.70M $725K $70.92M
Net Change in Cash $17.46M -$16.16M -$17.00M -$18.24M $8.02M $11.68M -$10.95M $11.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- 100.0% -- -- --
Operating Margin -212.9% -3.5% -225066.7% -2698.8% -353.3% --
Net Profit Margin -203.3% 9.0% -181216.7% -2635.4% -367.7% --
Return on Equity (ROE) -149.9% 3.1% -23.6% -12.7% -- --
Return on Assets (ROA) -52.3% 2.3% -23.3% -12.3% -32.9% -8.3%
Current Ratio 7.28x 14.26x 96.92x 51.01x 7.42x 40.69x
Quick Ratio 6.48x 13.81x 96.92x 50.40x 7.34x 40.26x
Debt to Equity 0.84x 0.00x 0.00x 0.00x -- --
Revenue Growth (YoY) -5.5% +297063.3% -97.7% -76.1% -- --
Net Income Growth (YoY) -2241.8% -- -- -- -- --
EPS Growth (YoY) -2275.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -1361.2% -- -- -- -- --
Free Cash Flow Growth (YoY) -1418.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -161.5% -185.0% -204.5% -212.9% -63.6% -52.8% -27.9% -3.5%
Net Profit Margin -163.6% -184.2% -200.0% -203.3% -56.1% -42.7% -16.1% 9.0%
Return on Equity (ROE) -- -1721.8% -322.9% -149.9% -54.2% -25.0% -6.8% 3.1%
Return on Assets (ROA) -79.5% -86.3% -68.8% -52.3% -21.5% -15.3% -4.8% 2.3%
Current Ratio 3.25x 3.48x 4.94x 7.28x 6.66x 6.17x 11.00x 14.26x
Quick Ratio 2.74x 2.97x 4.30x 6.48x 6.24x 5.69x 10.74x 13.81x
Debt to Equity -- 7.73x 1.57x 0.84x 0.66x 0.01x 0.00x 0.00x
Revenue Growth (YoY) +16.0% +114.2% +184.5% -67.6% +1471.6% +3043.4% -- --
Operating Income Growth (YoY) -- -- -- -187.9% -- -- -- --
Net Income Growth (YoY) -- -- -- -182.8% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -203.5% -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -204.3% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001671858) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal